Clareon
Device Ophthalmology
PDI 00380652486545
General payments
$5,217,048
Research payments
$6,200,439
Through program year 2025, $5,217,048 in general payments and $6,200,439 in research payments were reported against Clareon (Ophthalmology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,230,003 | 2,489 |
| 2025 | Research | $66,260 | 15 |
| 2024 | General | $1,620,059 | 13,989 |
| 2024 | Research | $1,181,390 | 344 |
| 2023 | General | $1,434,544 | 14,781 |
| 2023 | Research | $4,127,044 | 1,407 |
| 2022 | General | $860,676 | 8,663 |
| 2022 | Research | $518,759 | 106 |
| 2021 | General | $71,765 | 868 |
| 2021 | Research | $306,986 | 5 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
40,790 general · 1,877 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.